18 Recruiting Studies Using Neratinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Neratinib
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
📍 Moffitt Cancer Center — Tampa, Florida
GastroEsophageal Cancer
View Study & Checklist ➔Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
📍 Phoenix Children'S Hospital — Phoenix, Arizona
Solid Tumor
View Study & Checklist ➔Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
📍 Virginia Commonwealth University — Richmond, Virginia
Advanced Solid Tumor
View Study & Checklist ➔Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
Breast Cancer
View Study & Checklist ➔Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
📍 UC San Diego Health Moores Cancer Center — La Jolla, California
Metastatic Invasive Breast Cancer
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
📍 UCLA Medical Center — Los Angeles, California
Neurofibromatosis Type 2
View Study & Checklist ➔Neratinib in Combination With Ruxolitinib in Patients With mTNBC
📍 Baylor University Medical Center, Baylor Charles A Sammons Cancer Center — Dallas, Texas
Metastatic Triple-Negative Breast Carcinoma
View Study & Checklist ➔Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
📍 Emory University/ Winship Cancer Institute — Atlanta, Georgia
Anatomic Stage I Breast Cancer
View Study & Checklist ➔Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Metastatic Malignant Solid Neoplasm
View Study & Checklist ➔I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Neoplasms
View Study & Checklist ➔Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease
📍 University Health Network: Princess Margaret Cancer Centre — Toronto, Ontario
Breast Cancer
View Study & Checklist ➔INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Glioblastoma
View Study & Checklist ➔Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
📍 University of Illinois Cancer Center — Chicago, Illinois
Breast Cancer
View Study & Checklist ➔Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
📍 Stanford Cancer Center — Palo Alto, California
Gastric Cancer
View Study & Checklist ➔Using Tumor Models to Determine Treatments
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Pancreatic Ductal Carcinoma
View Study & Checklist ➔Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Malignant Female Reproductive System Neoplasm
View Study & Checklist ➔Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
📍 Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
Advanced Breast Cancer
View Study & Checklist ➔